Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  PCAS    PCA   FR0000053514

PCAS (PCA)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 05/18 04:05:39 pm
18.1 EUR   --.--%
04/24PCAS : Chiffre d'affaires au 31 Mars 2018
PU
04/24PCAS : Net sales as of march 31, 2018
GL
04/24PCAS : 1st quarter earnings
CO
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Latest news on PCAS
04/24PCAS : Chiffre d'affaires au 31 Mars 2018
PU
04/24PCAS : Net sales as of march 31, 2018
GL
04/24PCAS : 1st quarter earnings
CO
02/20PCAS : 2017 Annual Results
GL
02/15PCAS SA : annual earnings release
01/31PCAS : Net sales as of December 31, 2017
PU
01/31PCAS : Net sales as of december 31, 2017
GL
01/31PCAS : Net sales as of december 31, 2017
AQ
2017PCAS : Chiffre d'affaires au 30 septembre 2017
PU
2017PCAS : Résultats au 1er semestre 2017
PU
2017NOMBRE TOTAL DE DROITS DE VOTE ET D' : Août 2017
PU
2017PCAS SA : half-yearly earnings release
2017NOMBRE TOTAL DE DROITS DE VOTE ET D' : Juillet 2017
PU
2017PCAS : End of the liquidity contract between PCAS and KEPLER CHEUVREUX
GL
2017PCAS : sustained growth in net sales
GL
2017NOMBRE TOTAL DE DROITS DE VOTE ET D' : Juin 2017
PU
2017PCAS : Ex-dividend day for final dividend
FA
2017NOMBRE TOTAL DE DROITS DE VOTE ET D' : Mai 2017
PU
2017PCAS : Document de référence 2016
PU
2017PCAS : Annual Report 2016 PCAS
PU
2017PCAS : Sustained growth in Net sales
PU
2017PCAS : Project of strategic combination between Novacap and PCAS
PU
2017PCAS : 2016 Annual Results
PU
2017PCAS : 2016 Annual Results
GL
2017PCAS : Net Sales as at December 31, 2016
GL
2016PCAS : Acquisition of a leading R&D Center
PU
2016PCAS : Acquisition of a leading r&d center
GL
2016PCAS : at China INTER LUBRIC 2016
PU
2016PCAS : net sales as of 30 September, 2016
GL
2016PCAS : Ex-dividend day for interim dividend
FA
2016PCAS : 1st half 2016 earnings report continued organic growth
GL
2016PCAS : half-yearly earnings release
2016PCAS : Net sales for the 1st half of 2016
PU
2016PCAS : SUSTAINED GROWTH IN NET SALES FOR THE 1st HALF OF 2016
GL
2016PCAS : signs a global distribution agreement with MilliporeSigma
PU
2016PCAS : sign a global distribution agreement with MilliporeSigma
PU
2016PCAS : Signs a global distribution agreement with MilliporeSigma, enabling a bet..
GL
2016PCAS : Inauguration of a new workshop at the couterne site
PU
2016PCAS : Inauguration of a new workshop at the couterne site
GL
2016PCAS : confirms its PME SME eligibility
PU
2016PCAS : Collaboration Syngenta
PU
2016PCAS : Syngenta Collaboration
PU
2016PCAS : A new collaboration for enzyme optimization between syngenta and protéus ..
GL
2016PCAS : Allocation of free shares
GL
2016PCAS : Corporate name change
PU
2016PCAS : Corporate name change
GL
2016PCAS : Ex-dividend day for final dividend
FA
2016PCAS : enters into a manufacturing agreement with ABIVAX
PU
2016PCAS : Enters into a manufacturing agreement with abivax
GL
2016PCAS : Q1 2016 Net sales
PU
2016PCAS - 2016 Q1 SALES : Sharp growth in net sales again
GL
2016PCAS : US patent granted for PCAS new Cinacalcet production process
PU
2016PCAS : 2015 Annual Report
PU
2016PCAS : Shareholder's Letter
PU
2016PCAS : Presentation of 2015 performance
PU
2016PCAS : 2015 Earnings
PU
2016PCAS : 2015 earnings up sharply
GL
2016PCAS : 2015 Net Sales
PU
2016PCAS : 8% bonds dated - 31/12/2016 buy back
PU
2016PCAS : 8% bonds dated- 31/12/2016 buy back
GL
2016PCAS : 2015 sales - strong growth
GL
2015PCAS : Sales as of 30 september 2015, +4.8 % growth
GL
2015PCAS : ADEME acquires a stake in ENERSENS
PU
2015PCAS : Ademe acquires a stake in enersens as part of the 'investments for the fu..
GL
2015PCAS : Ex-dividend day for interim dividend
FA
2015PCAS : 2015 HYR - Very good operational performance Pharma focus yields strong g..
GL
2015PCAS : Sustained growth in net sales for the first half of 2015
GL
2015PCAS : Participation de PCAS au Forum d’affaires France-Chine à Paris le 1..
PU
2015PCAS : takes part in the China-France Business Forum held in Paris on July 1st, ..
PU
2015PCAS : reinforces its management team and hires several new staff members within..
GL
2015PCAS : reinforces its management team and hires several new staff members within..
PU
2015PCAS : Strengthens its foothold in pharmaceuticals in north america
GL
2015PCAS : 2015 - 2016 financial calendar
GL
2015PCAS : Obtains the "innovative business" label awarded by bpifrance
GL
2015PCAS : Ex-dividend day for final dividend
FA
1  2Next
Financials (€)
Sales 2018 227 M
EBIT 2018 20,6 M
Net income 2018 10,2 M
Debt 2018 47,9 M
Yield 2018 -
P/E ratio 2018 24,97
P/E ratio 2019 22,21
EV / Sales 2018 1,42x
EV / Sales 2019 1,34x
Capitalization 274 M
Chart PCAS
Duration : Period :
PCAS Technical Analysis Chart | PCA | FR0000053514 | 4-Traders
Technical analysis trends PCAS
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 18,8 €
Spread / Average Target 3,6%
EPS Revisions
Managers
NameTitle
Vincent Touraille CEO & Financial Communications Contact
Pierre Luzeau Chairman
Pierre Schreiner Chief Operating Officer
Eric Moissenot Deputy CEO-Finance & Administration
Gérard Guillamot Scientific Director
Sector and Competitors
1st jan.Capitalization (M$)
PCAS-0.11%323
JOHNSON & JOHNSON-11.36%332 184
PFIZER-1.41%212 424
NOVARTIS-6.55%202 969
ROCHE HOLDING LTD.-8.90%193 622
MERCK AND COMPANY5.10%158 916